These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1000 related items for PubMed ID: 16130596

  • 1. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M.
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [Abstract] [Full Text] [Related]

  • 2. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A.
    Ann Acad Med Stetin; 2005 Jan; 51(1):95-105. PubMed ID: 16496609
    [Abstract] [Full Text] [Related]

  • 3. Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
    Jastrzebskal M, Widecka K, Naruszewicz M, Ciechanowicz A, Janczak-Bazan A, Foltynska A, Goracy I, Chetstowski K, Wesotowska T.
    Nutr Metab Cardiovasc Dis; 2004 Oct; 14(5):259-69. PubMed ID: 15673060
    [Abstract] [Full Text] [Related]

  • 4. Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension.
    Jastrzebska M, Goracy I, Naruszewicz M.
    Thromb Res; 2003 Jun 15; 110(5-6):339-44. PubMed ID: 14592559
    [Abstract] [Full Text] [Related]

  • 5. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec 15; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 6. [The hemostasis parameters and ACE gene polymorphism in patients with essential hypertension treated with perindopril].
    Janczak-Bazan A.
    Ann Acad Med Stetin; 2006 Dec 15; 52(1):51-61; discussion 61-2. PubMed ID: 17131847
    [Abstract] [Full Text] [Related]

  • 7. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
    Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, Celentano E, Panico S, Di Minno G.
    Arterioscler Thromb Vasc Biol; 1997 Oct 15; 17(10):2082-7. PubMed ID: 9351375
    [Abstract] [Full Text] [Related]

  • 8. Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population.
    Kurzawińska G, Barlik M, Drews K, Różycka A, Seremak-Mrozikiewicz A, Ożarowski M, Klejewski A, Czerny B, Wolski H.
    Ginekol Pol; 2016 Oct 15; 87(4):271-6. PubMed ID: 27321098
    [Abstract] [Full Text] [Related]

  • 9. The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms.
    Moore JH, Smolkin ME, Lamb JM, Brown NJ, Vaughan DE.
    Clin Genet; 2002 Jul 15; 62(1):53-9. PubMed ID: 12123488
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D, Fatini C, Battaglini B, Gensini F, Fedi S, Falai M, Chioccioli M, Gori AM, Margheri M, Gensini GF.
    Int J Clin Lab Res; 2000 Jul 15; 30(4):179-85. PubMed ID: 11289708
    [Abstract] [Full Text] [Related]

  • 11. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
    Velickovic J, Jelicic M, Stojkovic O.
    Blood Coagul Fibrinolysis; 2021 Mar 01; 32(2):103-107. PubMed ID: 33555692
    [Abstract] [Full Text] [Related]

  • 12. Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease.
    Sakhteh M, Poopak B, Amirizadeh N, Shamshiri A, Bagheri A, Faranoush M.
    J Renin Angiotensin Aldosterone Syst; 2015 Dec 01; 16(4):1168-74. PubMed ID: 25501306
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the Association Between Polymorphisms within PAI-1 and ACE genes and Ischemic Stroke Outcome After rt-PA Therapy.
    Dušanović Pjević M, Beslac Bumbaširevic L, Vojvodic L, Grk M, Maksimović N, Damnjanović T, Novaković I, Kačar K, Pesic M, Perovic D, Savic M, Maksic V, Trickovic J, Jekic B.
    J Pharm Pharm Sci; 2019 Dec 01; 22(1):142-149. PubMed ID: 31013014
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension.
    Jeng JR, Harn HJ, Yueh KC, Jeng CY, Shieh SM.
    Am J Hypertens; 1998 Feb 01; 11(2):235-9. PubMed ID: 9524054
    [Abstract] [Full Text] [Related]

  • 15. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.
    J Periodontol; 2007 Jul 01; 78(7):1256-63. PubMed ID: 17608581
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H, Gejyo F, Suzuki Y, Suzuki S, Miyazaki R, Arakawa M.
    Kidney Int; 1998 Nov 01; 54(5):1659-69. PubMed ID: 9844142
    [Abstract] [Full Text] [Related]

  • 17. Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension.
    Roncal C, Orbe J, Rodriguez JA, Belzunce M, Beloqui O, Diez J, Páramo JA.
    Cardiovasc Res; 2004 Jul 01; 63(1):176-85. PubMed ID: 15194475
    [Abstract] [Full Text] [Related]

  • 18. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY.
    J Stroke Cerebrovasc Dis; 2007 Jul 01; 16(4):153-9. PubMed ID: 17689411
    [Abstract] [Full Text] [Related]

  • 19. Influence of PAI-1 gene promoter-675 (4G/5G) polymorphism on fibrinolytic activity after cardiac surgery employing cardiopulmonary bypass.
    Ozolina A, Strike E, Jaunalksne I, Serova J, Romanova T, Zake LN, Sabelnikovs O, Vanags I.
    Medicina (Kaunas); 2012 Jul 01; 48(10):515-20. PubMed ID: 23324247
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
    Sun L, Lv H, Wei W, Zhang D, Guan Y.
    J Endocrinol Invest; 2010 Feb 01; 33(2):77-82. PubMed ID: 19636212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.